Materials • Major Chemicals
$33.62 ▼ -0.51
(-1.49%)
MKT CAP: $24.34B • VOL: 7.36M
52W L $21 52W H $43
DOW // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $39.97B | $42.96B | $44.62B |
| YoY Revenue Growth % | -7.0% | -3.7% | — |
| Gross Profit | $2.53B | $4.61B | $19.63B |
| Gross Margin % | 6.3% | 10.7% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $810.6M | $1.47B | $6.28B |
| Operating Margin % | 2.0% | 3.4% | 14.1% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $2.25B | $3.02B | $7.89B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.03B | $2.91B | $5.20B |
| Capital Expenditures (CapEx) | $1.80B | $1.93B | $2.01B |
| Free Cash Flow (FCF) | -$766.6M | $980.6M | $3.19B |
| FCF Margin % | -1.9% | 2.3% | 7.1% |
| Return on Invested Capital (ROIC %) | 2.5% | 4.1% | 15.3% |
| Cash & Short-Term Equivalents | $3.82B | $2.19B | $5.89B |
| Total Debt (Short + Long Term) | $13.70B | $13.41B | $12.53B |
| Total Stockholders' Equity | $16.01B | $17.36B | $25.70B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR DOW.